Evid Invest
Who owns BLRXWhat BLRX owns — n/a

Who owns BioLineRx Ltd.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of BLRX from SEC Form 13F filings across 14 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 14 institutions disclosed 66,570 shares of BioLineRx Ltd. worth $207,718 — about 1.5% of shares outstanding; the largest disclosed holder is SUSQUEHANNA INTERNATIONAL GROUP, LLP. Source: SEC Form 13F filings, parsed by EvidInvest.

14

13F holders

$207,718

value, 2026 filers

1.5%

of shares outstanding (66,570 sh)

5

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BLRX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW30,911$95,8240.0%0.7%new
2RENAISSANCE TECHNOLOGIES LLCNEW15,412$48,0850.0%0.3%new
3CITADEL ADVISORS LLCNEW14,796$45,8680.0%0.3%new
4RHUMBLINE ADVISERS2,478$7,6790.0%0.1%+5.3%
5WELLS FARGO & COMPANY/MN2,000$6,2400.0%0%+14.3%
6BNP PARIBAS FINANCIAL MARKETS500$1,5500.0%0%-72.2%
7Nemes Rush Group LLC250$7800.0%0%0.0%
8UBS Group AG101$3150.0%0%-80.9%
9NewEdge Advisors, LLCNEW82$2560.0%0%new
10OSAIC HOLDINGS, INC.26$810.0%0%0.0%
11SBI Securities Co., Ltd.NEW10$310.0%0%new
12DANSKE BANK A/S2$60.0%0%0.0%
13Banque Cantonale Vaudoise1$1,0000.0%0%0.0%
14CITIGROUP INC1$30.0%0%-99.9%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.